Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development

Qinghua Zeng, Sharbani Phukan, Yanfei Xu, Maureen Sadim, Diana S. Rosman, Michael Pennison, Jie Liao, Guang Yu Yang, Chiang Ching Huang, Laura Valle, Antonio Di Cristofano, Albert De La Chapelle, Boris Pasche

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Transforming growth factor-β (TGF-β) signaling is frequently altered in colorectal cancer. Using a novel model of mice heterozygous for a targeted null mutation of Tgfbr1 crossed with ApcMin/+ mice, we show that ApcMin/+;Tgfbr1+/- mice develop twice as many intestinal tumors as ApcMin/+;Tgfbr1+/+ mice, as well as adenocarcinoma of the colon, without loss of heterozygosity at the Tgfbr1 locus. Decreased Smad2 and Smad3 phosphorylation and increased cellular proliferation are observed in the colonic epithelium crypts of ApcMin/+; Tgfbr 1+/- mice. Smad-mediated TGF-β signaling is preserved in both ApcMin/+;Tgfbr1+/+ and ApcMin/+;Tgfbr1 +/- intestinal tumors, but cyclin D1 expression and cellular proliferation are significantly higher in ApcMin/+;Tgfbr1 +/- tumors. These results show that constitutively reduced Tgfbr1-mediated TGF-β signaling significantly enhances colorectal cancer development and results in increased tumor cell proliferation. These findings provide a plausible molecular mechanism for colorectal cancer development in individuals with constitutively altered TGFBR1 expression, a recently identified common form of human colorectal cancer.

Original languageEnglish (US)
Pages (from-to)678-686
Number of pages9
JournalCancer Research
Volume69
Issue number2
DOIs
StatePublished - Jan 15 2009

Fingerprint

Haploinsufficiency
Colorectal Neoplasms
Transforming Growth Factors
Cell Proliferation
Neoplasms
Loss of Heterozygosity
Cyclin D1
Colon
Adenocarcinoma
Epithelium
Phosphorylation
Mutation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Zeng, Q., Phukan, S., Xu, Y., Sadim, M., Rosman, D. S., Pennison, M., ... Pasche, B. (2009). Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development. Cancer Research, 69(2), 678-686. https://doi.org/10.1158/0008-5472.CAN-08-3980

Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development. / Zeng, Qinghua; Phukan, Sharbani; Xu, Yanfei; Sadim, Maureen; Rosman, Diana S.; Pennison, Michael; Liao, Jie; Yang, Guang Yu; Huang, Chiang Ching; Valle, Laura; Di Cristofano, Antonio; De La Chapelle, Albert; Pasche, Boris.

In: Cancer Research, Vol. 69, No. 2, 15.01.2009, p. 678-686.

Research output: Contribution to journalArticle

Zeng, Q, Phukan, S, Xu, Y, Sadim, M, Rosman, DS, Pennison, M, Liao, J, Yang, GY, Huang, CC, Valle, L, Di Cristofano, A, De La Chapelle, A & Pasche, B 2009, 'Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development', Cancer Research, vol. 69, no. 2, pp. 678-686. https://doi.org/10.1158/0008-5472.CAN-08-3980
Zeng Q, Phukan S, Xu Y, Sadim M, Rosman DS, Pennison M et al. Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development. Cancer Research. 2009 Jan 15;69(2):678-686. https://doi.org/10.1158/0008-5472.CAN-08-3980
Zeng, Qinghua ; Phukan, Sharbani ; Xu, Yanfei ; Sadim, Maureen ; Rosman, Diana S. ; Pennison, Michael ; Liao, Jie ; Yang, Guang Yu ; Huang, Chiang Ching ; Valle, Laura ; Di Cristofano, Antonio ; De La Chapelle, Albert ; Pasche, Boris. / Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development. In: Cancer Research. 2009 ; Vol. 69, No. 2. pp. 678-686.
@article{5b6f5c71cf7e44bdb02f689e0ece0ba2,
title = "Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development",
abstract = "Transforming growth factor-β (TGF-β) signaling is frequently altered in colorectal cancer. Using a novel model of mice heterozygous for a targeted null mutation of Tgfbr1 crossed with ApcMin/+ mice, we show that ApcMin/+;Tgfbr1+/- mice develop twice as many intestinal tumors as ApcMin/+;Tgfbr1+/+ mice, as well as adenocarcinoma of the colon, without loss of heterozygosity at the Tgfbr1 locus. Decreased Smad2 and Smad3 phosphorylation and increased cellular proliferation are observed in the colonic epithelium crypts of ApcMin/+; Tgfbr 1+/- mice. Smad-mediated TGF-β signaling is preserved in both ApcMin/+;Tgfbr1+/+ and ApcMin/+;Tgfbr1 +/- intestinal tumors, but cyclin D1 expression and cellular proliferation are significantly higher in ApcMin/+;Tgfbr1 +/- tumors. These results show that constitutively reduced Tgfbr1-mediated TGF-β signaling significantly enhances colorectal cancer development and results in increased tumor cell proliferation. These findings provide a plausible molecular mechanism for colorectal cancer development in individuals with constitutively altered TGFBR1 expression, a recently identified common form of human colorectal cancer.",
author = "Qinghua Zeng and Sharbani Phukan and Yanfei Xu and Maureen Sadim and Rosman, {Diana S.} and Michael Pennison and Jie Liao and Yang, {Guang Yu} and Huang, {Chiang Ching} and Laura Valle and {Di Cristofano}, Antonio and {De La Chapelle}, Albert and Boris Pasche",
year = "2009",
month = "1",
day = "15",
doi = "10.1158/0008-5472.CAN-08-3980",
language = "English (US)",
volume = "69",
pages = "678--686",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development

AU - Zeng, Qinghua

AU - Phukan, Sharbani

AU - Xu, Yanfei

AU - Sadim, Maureen

AU - Rosman, Diana S.

AU - Pennison, Michael

AU - Liao, Jie

AU - Yang, Guang Yu

AU - Huang, Chiang Ching

AU - Valle, Laura

AU - Di Cristofano, Antonio

AU - De La Chapelle, Albert

AU - Pasche, Boris

PY - 2009/1/15

Y1 - 2009/1/15

N2 - Transforming growth factor-β (TGF-β) signaling is frequently altered in colorectal cancer. Using a novel model of mice heterozygous for a targeted null mutation of Tgfbr1 crossed with ApcMin/+ mice, we show that ApcMin/+;Tgfbr1+/- mice develop twice as many intestinal tumors as ApcMin/+;Tgfbr1+/+ mice, as well as adenocarcinoma of the colon, without loss of heterozygosity at the Tgfbr1 locus. Decreased Smad2 and Smad3 phosphorylation and increased cellular proliferation are observed in the colonic epithelium crypts of ApcMin/+; Tgfbr 1+/- mice. Smad-mediated TGF-β signaling is preserved in both ApcMin/+;Tgfbr1+/+ and ApcMin/+;Tgfbr1 +/- intestinal tumors, but cyclin D1 expression and cellular proliferation are significantly higher in ApcMin/+;Tgfbr1 +/- tumors. These results show that constitutively reduced Tgfbr1-mediated TGF-β signaling significantly enhances colorectal cancer development and results in increased tumor cell proliferation. These findings provide a plausible molecular mechanism for colorectal cancer development in individuals with constitutively altered TGFBR1 expression, a recently identified common form of human colorectal cancer.

AB - Transforming growth factor-β (TGF-β) signaling is frequently altered in colorectal cancer. Using a novel model of mice heterozygous for a targeted null mutation of Tgfbr1 crossed with ApcMin/+ mice, we show that ApcMin/+;Tgfbr1+/- mice develop twice as many intestinal tumors as ApcMin/+;Tgfbr1+/+ mice, as well as adenocarcinoma of the colon, without loss of heterozygosity at the Tgfbr1 locus. Decreased Smad2 and Smad3 phosphorylation and increased cellular proliferation are observed in the colonic epithelium crypts of ApcMin/+; Tgfbr 1+/- mice. Smad-mediated TGF-β signaling is preserved in both ApcMin/+;Tgfbr1+/+ and ApcMin/+;Tgfbr1 +/- intestinal tumors, but cyclin D1 expression and cellular proliferation are significantly higher in ApcMin/+;Tgfbr1 +/- tumors. These results show that constitutively reduced Tgfbr1-mediated TGF-β signaling significantly enhances colorectal cancer development and results in increased tumor cell proliferation. These findings provide a plausible molecular mechanism for colorectal cancer development in individuals with constitutively altered TGFBR1 expression, a recently identified common form of human colorectal cancer.

UR - http://www.scopus.com/inward/record.url?scp=58349120416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58349120416&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-08-3980

DO - 10.1158/0008-5472.CAN-08-3980

M3 - Article

C2 - 19147584

AN - SCOPUS:58349120416

VL - 69

SP - 678

EP - 686

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 2

ER -